The ASCPT LMIC Accelerator Program funds travel and networking for clinical pharmacologists and translational scientists from low-to-middle-income countries to attend the ASCPT Annual Meeting, aiming to promote diversity, equity, and inclusion in global clinical pharmacology forums.

- Applicant must reside in a World Bank-identified LMIC (e.g., Nigeria qualifies) - Applicant must be a clinical pharmacologist or translational scientist (not an AI/biotech startup founder) - Preference for those who would benefit from science and networking at the ASCPT annual meeting - Commitment to participate in quarterly virtual networking sessions and attend the in-person meeting in Denver, CO (March 4-6, 2026) - Application includes CV, cover letter, and application form; no explicit scoring rubric provided but likely prioritizes relevance to clinical pharmacology and LMIC impact

No specific past winners named on the page; the program launched in 2023 as a travel grant and awards 10 grants of $7,500 each. Typical winners are likely early-career clinical pharmacologists, pharmacists, or translational scientists from LMICs working in academic or clinical settings, not startup founders.

A clinical pharmacologist or translational scientist based in an LMIC (e.g., Nigeria, India, Kenya) who conducts research in drug metabolism, pharmacokinetics, or therapeutic optimization, and who would gain professional development and networking from attending the ASCPT Annual Meeting. The ideal applicant is affiliated with a university, hospital, or research institute, not a for-profit venture.